Sign inGet started

Costa Carlos

Insider CIK 1939167 · FHTX Chief People Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
FHTX Foghorn Therapeutics Inc. A Award deriv2026-01-302026-02-02230,000$5.71 $1.31M230,000SEC↗
FHTX Foghorn Therapeutics Inc. A Award deriv2025-01-222025-01-24115,000$4.37 $502.6K115,000SEC↗
FHTX Foghorn Therapeutics Inc. M Exercise deriv2024-09-232024-09-24857— $039,789SEC↗
FHTX Foghorn Therapeutics Inc. S Sale2024-09-232024-09-24857$10.17 $8.7K0SEC↗
FHTX Foghorn Therapeutics Inc. M Exercise2024-09-232024-09-24857$3.72 $3.2K857SEC↗
FHTX Foghorn Therapeutics Inc. M Exercise deriv2024-09-202024-09-2435,756— $040,646SEC↗
FHTX Foghorn Therapeutics Inc. M Exercise2024-09-202024-09-2435,756$3.72 $133.0K35,756SEC↗
FHTX Foghorn Therapeutics Inc. S Sale2024-09-202024-09-2435,756$10.04 $359.0K0SEC↗
FHTX Foghorn Therapeutics Inc. M Exercise deriv2024-09-182024-09-2011,574— $076,402SEC↗
FHTX Foghorn Therapeutics Inc. S Sale2024-09-182024-09-2011,574$10.05 $116.3K0SEC↗
FHTX Foghorn Therapeutics Inc. M Exercise2024-09-182024-09-2011,574$3.72 $43.1K11,574SEC↗
FHTX Foghorn Therapeutics Inc. M Exercise deriv2024-09-172024-09-1810,272— $087,976SEC↗
FHTX Foghorn Therapeutics Inc. S Sale2024-09-172024-09-1810,272$10.04 $103.1K0SEC↗
FHTX Foghorn Therapeutics Inc. M Exercise2024-09-172024-09-1810,272$3.72 $38.2K10,272SEC↗
FHTX Foghorn Therapeutics Inc. M Exercise deriv2024-09-162024-09-18400— $098,248SEC↗
FHTX Foghorn Therapeutics Inc. S Sale2024-09-162024-09-18400$10.00 $4.0K0SEC↗
FHTX Foghorn Therapeutics Inc. M Exercise2024-09-162024-09-18400$3.72 $1.5K400SEC↗
FHTX Foghorn Therapeutics Inc. A Award deriv2024-01-242024-01-2590,000$3.06 $275.4K90,000SEC↗
FHTX Foghorn Therapeutics Inc. A Award deriv2023-01-262023-01-3065,000— $065,000SEC↗
FHTX Foghorn Therapeutics Inc. A Award deriv2022-08-012022-08-0350,000— $050,000SEC↗